Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDA: Maintenance Pemetrexed in Advanced NSCLC
NCT02004184Phase 3Terminated
- Sponsor
- Norwegian University of Science and Technology
- Start
- Dec 2013
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Norwegian University of Science and Technology. Started Dec 2013; status: terminated.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02004184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004184.